| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  HBOX Therapies Delivering therapies through targeted hyperoxygenation We are developing miniaturized hyperoxygenation therapies! The first application for our technology is miniaturized respiratory assist in patients suffering from lung failure. Type: | 2 | 0 | 2 | 8 |
 |  SOMAÍ Pharmaceuticals We Craft Care SOMAÍ Pharmaceuticals is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio. At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine. SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships … Type: | 0 | 0 | 0 | 48 |
 | LightOx Ltd Light Activated Technologies for treating cancers and rare diseases Lightox has developed a new drug for the treatment of early stage oral cancers. The topically applied formulation allows for specific delivery to the lesion and is activated by a specific wavelength of light. Type: | 1 | 0 | 1 | 15 |
 | Dermadry Laboratories inc. Creators of the anti-sweat device. Dermadry is the world's leading manufacturer of iontophoresis machines for the treatment of hyperhidrosis, a medical condition characterized by excessive sweating that affects approximately 1 in 20 people worldwide. We offer three tailored solutions to treat the three areas most commonly affected by hyperhidrosis: the hands, feet, and underarms. Our Canadian-made range of iontophoresis machines include the Dermadry Hands & Feet, Dermadry Underarms, and the all-in-one Dermadry Total. Our FDA cleared and CE marked iontophoresis machines are an effective and non-invasive way to treat excessive sweating from the comfort and privacy of your home. During … Type: | 0 | 0 | 0 | 14 |
 |  Drug and Alcohol Testing Institute (DAT Institute) Promote educational opportunities, advance "best practices," and benchmarking opportunities for DER's. Program Managers, Promoting a drug and alcohol-free workplace by advancing professionalism through quality education and best practices. Education, Networking, Regulatory Compliance, Drug Testing, Alcohol Testing, Safety, and Human Resources Type: | 2 | 0 | 2 | 1 |
 | Cellulis Automation and standardization of cryopreservation processes for Cell Therapies Cellulis (formerly ZF Biotox) provides disruptive cryopreservation technologies in a broad range of biotechnology fields aiming to innovate CELL THERAPY solutions, to streamline BIOPROCESSING production, to enhance BIOBANKING and to improve High Throughput Screening (HTS) campaigns. Frozen Cells in Microplates Ready to Use., Final product formulation for cryopreserved cell therapy, and Cryopreservation of Cell Therapies Type: | 0 | 0 | 0 | 3 |
 | Biosantech [Automatic translation follows] TO DATE, THE MOST ADVANCED THERAPEUTIC VACCINE AGAINST AIDS IN THE WORLD BIOSANTECH, created in April 2011 by Roger and Corinne TREGER is an innovative company with a NORTH / SOUTH equitable vocation based in Sophia Antipolis Valbonne in the Provence-Alpes Cote d'Azur region. BIOSANTECH aims to promote and develop an effective vaccine on all variants of the AIDS virus. BIOSANTECH has an exclusive cooperation agreement with the CNRS and the University of Aix Marseille and owns the exclusive license to valorize and market the vaccine patents from the "TAT Oyi". BIOSANTECH, currently has the only therapeutic … Type: | 2 | 2 | 0 | 7 |
 | Spiderwort Inc. Developing revolutionary biomaterials for regenerative medicine. Spiderwort Inc. is a tissue engineering company specializing in the development of transformative biomaterials for repairing and regenerating tissues within the human body. Type: | 0 | 0 | 0 | 21 |
 | DTU Health Tech Technology for human health and well-being We develop health technology that makes life better for people. DTU Health Tech educates the engineers of the future, and develop new technology and solutions with a vision to improve people's life before, during and after they are patients. We do this in close collaboration with the health sector, industry, academia and other health partners, because we believe that the best results and ideas often occur in a close collaboration between different sectors. Health technology, Bioinformatics, Biomimetics, Biotherapeutic engineering, Digital health, Drug delivery, Immunology, Hearing research, Magnetic resonance, Medical isotopes, Dosimetry, Optical sensing, Ultrasound, … Type: | 3 | 0 | 3 | 150 |
 | Clarity Make brain health accessible to everyone, everywhere. Clarity leverages light and sound to pioneer a new category of therapeutics for neurological conditions. Type: | 6 | 2 | 5 | 26 |
 | 3D Bio-Tissues Applying biology to the creation of 3D structured tissues such as cultivated meat, lab-grown leather, skin and cornea! We are an ambitious start up, aiming to bring functional tissue engineered products to the market. Our unique technology creates tissues with the same nanoscale structural features found in actual living tissue. This allows our tissues to be truly functional and not a random mass of cells and materials. We are taking the lead on creating 100% lab grown meat, that means scaffold free! We are also wholly owned by BSF enterprise which is listed company, in fact we are the only … Type: | 1 | 1 | 0 | 14 |
 | Akari Therapeutics, Plc Developing novel advanced therapies to address unmet needs of patients with autoimmune & inflammatory diseases. Akari Therapeutics, Plc (Nasdaq: AKTX) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. Akari’s lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Akari’s pipeline includes a Phase 3 clinical trial program investigating nomacopan for severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). Akari has been granted Orphan Drug, Fast Track and Rare Pediatric Disease designations from the FDA for nomacopan for the treatment of pediatric HSCT-TMA and orphan drug designation … Type: | 0 | 0 | 0 | 15 |
 | Cellply Unravelling immune system function, one cell at a time Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented … Type: | 0 | 0 | 0 | 36 |
 | Acesion Pharma Danish biotech developing novel treatments for Atrial Fibrillation Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting the so-called SK channels. These are ion channels present in the heart where they are relevant for regulating the cardiac rhythm. Blocking this ion channel with a selective drug molecule constitutes a novel and promising target for developing improved treatment of AF. Type: | 0 | 0 | 0 | 18 |
 | Sitryx Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therapies Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at … Type: | 3 | 2 | 3 | 51 |
 | MedTrace Pharma A/S We innovate medical imaging to help health care professionals diagnose patients better and faster. MedTrace is striving to minimize diagnostic uncertainty through better perfusion imaging. Perfusion imaging provides medical professionals with a functional understanding of the organs blood supply inside the patient. MedTrace is developing a solution that will help healthcare providers diagnose patients more accurately and quickly. Our solution allows for absolute blood flow quantification based upon the PET tracer 15O-water, which has long been acknowledged as the gold standard tracer for non-invasive blood flow quantification. Our innovative solution is intended to making 15O-water practically available right next to … Type: | 0 | 0 | 0 | 45 |
 | AbolerIS Pharma The Immune system under control Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases. Type: | 5 | 2 | 0 | 16 |
 | Pathios Therapeutics Using human genetics to transform cancer outcomes Pathios Therapeutics are world-leading experts with unique expertise in GPCR drug development, focused on GPR65 as a high-value immunology target with robust genetic links to multiple human diseases. Our clinical-stage oncology programme leverages cutting-edge proprietary genetic insights, transcriptomics, and functional immunology of GPR65 as a key immune cell sensor of acidosis in multiple pathological environments, to bring about a revolutionary new approach to treating a broad spectrum of cancers. We are also building an emerging pipeline in neuroinflammatory and neurodegenerative disorders leveraging the broader immunological roles of this receptor in cell types such … Type: | 2 | 0 | 2 | 19 |
 | Synamics Therapeutics Pioneering AI-Driven Drug Discovery to Combat Drug Resistance At Synamics Therapeutics, our innovative strategy is not just about treating cancer—it's about staying one step ahead. The heart of our approach lies in our advanced AI-driven resistance modeling. This allows us to not only confront existing cancer mutations but also to proactively anticipate and target potential future mutations. By predicting these future resistance pathways, our AI model guides the design of our small molecules to effectively combat evolving cancer threats. This forward-thinking approach ensures the sustained efficacy of our therapies, significantly enhancing patient outcomes and leading the way in the evolution … Type: | 4 | 0 | 3 | 9 |
 | TOLREMO therapeutics Stopping non-genetic cancer drug resistance as it emerges TOLREMO therapeutics' mission is to prevent non-genetic cancer drug resistance by dismantling the earliest defense to targeted therapies. Led by phenotypic insights, we discovered a pivotal mechanism that governs critical transcriptional resistance pathways. Our clinical compound TT125-802 is an orally available small molecule inhibitor designed to block these survival techniques to significantly improve the response rates and durability of established treatments. By stopping cancer drug resistance as it emerges, we aim to surmount a universal challenge for current and future targeted therapies for lasting patient benefit. Drug Discovery, Drug Development, Cancer Drug … Type: | 2 | 0 | 2 | 15 |
 | SOLID Therapeutics An early-stage oncology company aiming to treat solid tumors SOLID Therapeutics is an early-stage oncology company spun out of CBMR at the University of Copenhagen. We are developing novel cancer therapeutics with dual mode of action targeting both cancer cells and immune cells to treat solid tumors. Type: | 1 | 0 | 1 | 9 |
 | HHC medical Revolutionizing drug delivery HHC medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Drug Delivery, Genetic therapies, and Enabling life-altering therapies Type: | 1 | 0 | 1 | 30 |
 | OKYO Pharma OKYO focuses on novel GPCR based therapeutics for eye diseases of unmet need and non-opioid analgesics for chronic pain. OKYO Pharma focuses on: A novel class of membrane-anchored Chemerin receptor GPCR agonist that targets the inflammatory pathways to treat dry eye syndrome, uveitis and allergic conjunctivitis. An agonist for MAS-Related G Protein-Coupled Receptor (MRGPR), a non-opioid analgesic, for ocular and chronic pain management using novel topical and nasal formulations. Type: | 2 | 0 | 0 | 8 |
 | Mikrobiomik rethinking microbiome Mikrobiomik is a bio-pharmaceutical company founded to conduct research into and develop medicines based on the human microbiome. Our vision We aspire to be the first company in the world to market a medicine based on faecal microbiota in the EU. To that end, we are holding talks with both the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) with a view to establishing protocols on the regulatory requirements for securing an MAA (Marketing Authorization Application) via centralised procedure. Our values Mikrobiomik seeks to lead the paradigm shift entailed by designing therapeutic … Type: | 1 | 0 | 1 | 20 |
 | Bastion Therapeutics Creating a future where inflammatory disorders are curable Bastion Therapeutics is a preclinical stage biotech with a mission to develop novel Treg cell therapies to address the unmet clinical need for inflammatory disorders. We leverage our proprietary GRITTM platform technology to engineer Tregs to modulate the immune system and overcome challenges associated with previous generations of Treg cell therapies. Our vision is to provide life-changing therapies that are efficacious, durable and safe to patients suffering from inflammatory disorders. Type: | 5 | 0 | 5 | 9 |
 | BioLamina Cell-specific culture matrices for improved cell functionality BioLamina is a Swedish biotechnology company with a global presence, offering cell culture matrices for primary cells. We offer an expansive portfolio of recombinant laminin proteins for a variety of applications, including the reliable expansion of pluripotent cell and differentiation and maintenance of specialized cell types. Our chemically defined and xeno-free laminin cell culture matrices allow you to imitate the natural cell-matrix interaction in vitro. Laminins are key components of the extracellular matrix. Through their interactions with specific receptors, laminins trigger the authentic cellular responses, pivotal for cell anchorage, survival, proliferation, migration, organization, … Type: | 0 | 0 | 0 | 114 |
 | Centenara Labs AG Helping people live longer, healthier lives. Centenara Labs is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding of the biology of aging, alongside technological advances in biopharmaceutical R&D, to progress a new generation of medicines that will help people to age better and live longer. Type: | 0 | 0 | 0 | 14 |
 | AlveoGene Transforming Rare Respiratory Disease Outcomes Using Inhaled Genes Therapy AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy. AlveoGene has been created by OSE, Harrington and OCC in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC). The GTC was founded in 2001 to catalyse the application of pioneering research to gene therapy development and manufacturing related to cystic fibrosis and other respiratory diseases, and originated at Imperial College London and the Universities of Oxford and Edinburgh. AlveoGene has secured an exclusive licence to a proprietary and validated … Type: | 1 | 0 | 1 | 3 |
 | Broken String Biosciences Turning breaks into breakthroughs Broken String Bioscience’s technology platform, INDUCE-seq®, supports the development of cell and gene therapies that are safer by design.INDUCE-seq®, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs. Type: | 2 | 0 | 1 | 40 |
 | ImmuneBridge Amplifying nature’s innate intelligence to fight cancer ImmuneBridge is developing allogeneic immunotherapies for cancer. Our core technology drives the expansion of cord blood derived immune stem cells and establishes a novel, flexible, consistent and abundant cellular source for immunotherapies. We are currently pursuing natural killer cell products for hematological malignancies. Next we will use the unique advantages of our cellular source to tackle solid tumors. Platform ImmuneBridge is creating a platform of scalable allogeneic immune cell therapies from cord blood. Our proprietary technology, including a novel small molecule, expands cord blood HSPCs over 100,000-fold while maintaining full immune multipotency, with … Type: | 0 | 0 | 0 | 26 |
 | Odyssey SpaceWorks R&D labs in space enabling observation and engineering of biological systems from earth. Odyssey SpaceWorks builds science labs in space enabling researchers to make discoveries that are impossible on earth. Our R&D labs which offer direct control from earth, allow for observation, construction, and engineering of biological systems in a reliable, predictable fashion. Applications include Tissue Engineering, Therapeutics, Cancer Biology, Agriculture, Drug Safety, and more. Type: | 0 | 0 | 0 | 4 |
 | cnsTherapy We make chronic pain patients pain-free using a medical device and behavioral therapy without drugs, surgery, implants. We make chronic pain patients pain-free using a neuromodulation device and behavioral therapy without medication, surgery, implants, or cannabis. pain, behavioral therapy, and fibromyalgia Type: | 0 | 0 | 0 | N/A |
 | Shield Therapeutics plc Helping patients become people again Shield is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead product Accrufer®/Feraccru® (ferric maltol). The Group has launched Accrufer® in the US and Feraccru® is commercialized in the UK and European Union by Norgine B.V., who also have the marketing rights in Australia and New Zealand. Shield also has an exclusive license agreement with Beijing Aosaikang Pharmaceutical Co., Ltd., for the development and commercialization of Accrufer® / Feraccru® in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co., Ltd. in the Republic of Korea, and with … Type: | 0 | 0 | 0 | 74 |
 | Axithra Rapid Therapeutic Drug Monitoring Axithra is a spin-off from Ghent University and imec, developing a platform to quickly and accurately measure and monitor drug concentrations in blood, paving the way for treatments tailored to the specific needs of each individual, at any given time. The first application is focusing on personalizing beta-lactam antibiotics treatments in the intensive care unit. The company’s platform is based on proprietary optical and photonics technology and will allow physicians to optimize patient care by enabling personalized treatments. Type: | 0 | 0 | 0 | 11 |
 | ThirtyFiveBio Applying proprietary understanding of GPR35 biology to develop novel small-molecule modulators. ThirtyFiveBio is an early-stage drug discovery company that was established in 2021 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs. Based in Oxford, UK, the company is founded upon a deep understanding of the biology of GPR35. We are currently engaged in a fully enabled drug discovery program to identify novel small-molecule modulators of GPR35 Type: | 1 | 0 | 1 | 15 |
 | BMG [Automatic translation follows] The Federal Ministry of Health uses this channel to inform you about current health policy projects and laws. You can find more information on the pages of the authorities of our division 👇 Current topics of the BMG: www.gesundheitsministerium.de Health promotion and prevention: www.bzga.de Infectious diseases: www.infectionsschutz.de Disease surveillance and prevention: www.rki.de Vaccines and biomedical drugs: www.pei.de Medicines and medical products: www.bfarm.de You will also find our netiquette and imprint here: Netiquette: https://www.bundesgesundheitsministerium.de/social-media-netiquette.html Imprint: https://www.bundesgesundheitsministerium.de//impressum Type: | 26 | 7 | 5 | 199 |
 | Beckman Coulter Life Sciences (formerly Labcyte Inc.) Echo liquid handlers and Access workstations are now Beckman Coulter Life Sciences products. Labcyte is now Beckman Coulter Life Sciences! Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality … Type: | 4 | 1 | 3 | 54 |
 | Biotech Primer Life Science Training From Industry Experts Biotech Primer delivers current, relevant training to help professionals understand the science, business, and regulatory processes essential to the Biotechnology, Pharmaceutical, Molecular Diagnostics and Medical Device industries. With continuously updated materials and industry experts behind the podium, we provide the most engaging instruction anywhere. Since we opened in 2001, we have trained an estimated 150,000 people worldwide to date. We help prepare companies make strategic business decisions, navigate important regulatory hurdles, and move healthcare products from the bench to the bedside. We offer a diverse range of education, from on-demand micro classes, live and … Type: | 1 | 0 | 0 | 9 |
 | CenterWatch, A WCG Company The Trusted Source for Clinical Trial Information Since 1994, CenterWatch, A WCG Company has been the recognized global leader in providing clinical trials information to professionals working at sponsors, CROs, research sites and niche service providers. Today, WCG CenterWatch delivers critical industry insights to 150,000 life science executives every week through its newsletters, conferences, webinars, books, in-depth market surveys, industry profiles and clinical databases. And millions of patients and caregivers start their search for clinical trials with CenterWatch, with one of the largest clinical trial databases on the internet, CenterWatch iConnect. Clinical Trials Information, FDA Drugs Information, Clinical Research Market … Type: | 3 | 1 | 0 | 12 |
 | Harmonic Drive LLC Empower Your Robot® with lightweight gears and actuators. Harmonic Drive LLC designs and manufactures precision servo actuators, gearheads and gear component sets. We work with industry-leading customers and companies of all sizes to provide both standard product and, in most cases, custom-engineered solutions. Harmonic Drive LLC provides high precision, high performance products to meet customer’s mission critical application requirements. With over 50 years of experience, our expert engineering and production teams continually develop enabling technologies for the evolving motion control market. Sales Offices in Long Island, NY, Chicago, IL and San Jose, CA are staffed with degreed sales engineers, available … Type: | 20 | 1 | 2 | 112 |
 | SureCall Cell Phone Signal Boosters to Raise Your Bars SureCall® specializes in the design and manufacture of cell phone signal boosters, antennas and accessories. Our signal boosters dramatically improve cellular reception for homes, businesses, vehicles and watercraft. Our flagship product line of FCC-approved cell phone signal boosters enhance the range and reception for all North American cellular carriers, including voice, text and 4G LTE data. Founded in 2001 and based in the Silicon Valley California, SureCall is the cell phone signal booster leader in combining high quality technology with innovative designs, producing award-winning boosters that dramatically improve cell phone reception. With … Type: | 6 | 0 | 2 | 41 |
 | Sutro Biopharma, Inc. Changing the future of Oncology Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FolRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media … Type: | 6 | 1 | 5 | 313 |
 | Exagen Inc. A patient focused, discovery driven life science company. Exagen Inc. is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology and Autoimmune diseases. Committed to Personalized Medicine, our AVISE tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. For more information on our company, please visit www.Exagen.com. For more information on AVISE testing services, please visit www.AviseTest.com. Read our Social Media Terms of Use here: http://bit.ly/smtou Diagnostic Testing, Prognostic Testing, Therapeutic Drug Monitoring, and … Type: | 2 | 1 | 2 | 195 |
 | Research!America: Discovery. Innovation. Health. The Research!America alliance advocates for science, discovery and innovation to achieve better health for all. The Research!America alliance advocates for science, discovery, and innovation to achieve better health for all. We urge Congress and the administration to increase funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality (AHRQ), Food and Drug Administration (FDA) and National Science Foundation (NSF) at levels that keep pace with scientific opportunity. We also advocate for federal funding for global health research and a legislative and regulatory climate that stimulates growth in private sector … Type: | 8 | 3 | 9 | 52 |
 | J. Craig Venter Institute The J. Craig Venter Institute was formed in October 2006 through the merger of several affiliated and legacy organizations — The Institute for Genomic Research (TIGR) and The Center for the Advancement of Genomics (TCAG), The J. Craig Venter Science Foundation, The Joint Technology Center, and the Institute for Biological Energy Alternatives (IBEA). Today all these organizations have become one large multidisciplinary genomic-focused organization. With more than 250 scientists and staff, more than 250,000 square feet of laboratory space, and locations in Rockville, Maryland and La Jolla, California, JCVI is a world leader in genomic research. Please visit our web … Type: | 12 | 5 | 5 | 198 |
 | National Comprehensive Cancer Network® (NCCN®) An alliance of leading cancer centers devoted to patient care, research, and education. The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and … Type: | 7 | 4 | 3 | 212 |
 | Acceleron Pharma Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Type: | 6 | 1 | 4 | 69 |
 | TotalWellness TotalWellness helps inspire healthier living with flexible programs and services that anyone can use. Welcome to TotalWellness! Since 1998, we've been dedicated to enhancing workplace health and happiness through tailored wellness services. Our offerings include biometric screenings, corporate flu shots, COVID-19 vaccinations, and a comprehensive wellness portal—all designed to support better wellness programs for your employees. At TotalWellness, we’re more than just a service provider; we’re your partner in fostering a healthier, happier workplace. We believe that the true value of a wellness program lies in its long-term positive impact on each employee's life. Ready to elevate your company's health … Type: | 2 | 1 | 1 | 341 |
 | Pet Resource Center of Kansas City Ending pet homelessness through education and supportive services for pet owners in need. SNKC is a 501(c)(3) formed in 2002 that serves the Greater Kansas City Community. You are an important part of our team! Your support decreases the number of homeless, unwanted, and neglected pets in our community and entering our area shelters, as well as increases the quality of care for pets and strengthens the animal-human bond in the Kansas City Community. Mission Statement Our mission is to decrease pet homelessness, increase pet retention, and improve the quality of life for pets through education and supportive services for … Type: | 0 | 0 | 0 | 41 |
 | University Gastroenterology, LLC University Gastroenterology is a 24-member single specialty group providing patient friendly, cutting edge care for diseases of the liver and gastrointestinal tract. Our doctors are regionally recognized for their expertise in general gastroenterology, inflammatory bowel disease, liver disease, and therapeutic endoscopy. Our group has major campuses in Providence, East Greenwich, and Portsmouth. Each campus houses a state-of-the-art ambulatory Endoscopy Center that provides a caring and cost effective environment. Our group also provides inpatient consultative services at Rhode Island Hospital, Miriam Hospital, Kent County Hospital, Newport Hospital, and Roger Williams Hospital. Referrals are welcome. Gastroenterology and Liver Type: | 0 | 0 | 0 | 70 |
 | Horsepower Technologies Horsepower TechnologiesTM is an animal healthcare and technology company dedicated to combating equine lameness through the commercialization of products that reduce its incidence as well as the rehabilitation times associated with lameness. Horsepower Technologies first product, FastTrackTM, is the world’s first rehabilitative orthotic for horses which enables safer and early return to exercise during lameness rehabilitation. FastTrackTM is designed to help rehabilitate horses that have sustained “flexor apparatus” injuries; a series of tendons and ligaments running down the back of the leg. Based on years of innovation and extensive research, FastTrackTM has scientifically demonstrated that it can limit excessive extension … Type: | 1 | 0 | 1 | 2 |
 | Sputnik V The first registered vaccine against COVID-19 Sputnik V is the world’s first registered COVID-19 vaccine with proven 91.6% efficacy, based on a human adenoviral vector platform. Registered in over 70 countries. Type: | 4 | 0 | 1 | 1 |
 | Pranarôm Pranarôm, Pioneer in Scientific Aromatherapy for 30 years. World reference in Scientific Aromatherapy for 30 years, Pranarôm is the expert in natural and effective solutions developed from 100% pure, integral and organic chemotyped essential oils. Essential supplements or substitutes for drug treatments, Pranarôm synergies offer targeted responses in all areas of health and adapted for the whole family. Essential oils, aromatherapy, aromatherapie, santénaturelle, Vegetal oils, and naturalhealth Type: | 2 | 0 | 2 | 188 |
 | Cosmosoft Slimming devices for professionals and individuals Cosmosoft is a French designer, manufacturer and distributor of professional slimming equipment for more than 15 years. Created in 1998 by Cosmosoft, this technique provides a 100% natural way of stimulating the release of adipose cells for aesthetic and therapeutic purposes by activating the cells with a BioMagnetic field. Presents in the world with more than 2000 equipped centers, Cosmosoft devices are marketed through 3 divisions : - Beauty devices : BodySculptor & LipiDrainor slimming devices - Medical devices : ReduStim, a class IIa medical devices for reducing abdominal fat. - Fitness : MyoSculptor, … Type: | 1 | 0 | 0 | 9 |
 | UroMems UroMems is a biotechnology company based out of 5, rue Raymond Chanas, 38320, Eybens, FRANCE Urologie and Dispositifs médicaux Type: | 13 | 2 | 0 | 63 |
 | Galactica Biotech Galactica Biotech provides a drug repurposing method to identify novel applications for molecules in the market and in development for major and orphan diseases, reducing risk for patients and time and cost for companies. Our Mission With our specialized knowledge we are targeting to set new standards in the pharmaceutical industry adding value to old drugs and contributing to the health of people. Drug Discovery, Molecule characterization, Drug repurposing, and Novel compound applications Type: | 0 | 0 | 0 | 1 |
 | Akamis Bio Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer Akamis is a clinical-stage oncology company whose mission is to leverage its groundbreaking T-SIGn® platform to positively impact the lives of people living with cancer. We are developing a portfolio of solid tumor-targeted T-SIGn® therapeutics which aim to enable a patient’s own immune system to recognize, attack, and clear their cancer. Akamis’ growing pipeline of T-SIGn® therapeutics is anchored by its lead clinical-stage program, NG-350A, which is being investigated in an ongoing Phase 1 clinical study in patients with metastatic or advanced epithelial tumors. … Type: | 5 | 2 | 3 | 52 |
 | Carisma Therapeutics Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors Carisma Therapeutics Inc. is a clinical stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. Type: | 4 | 1 | 3 | 82 |
 | Platinum Informatics Ltd. Changing the world one experiment at a time. Platinum Informatics provides cloud-based software solutions which lay the foundations to manage big data and ensure reproducible results, whilst overcoming the challenges of remote working. With a focus on application in early-stage drug, vaccine and biomarker discovery in the growing area of precision medicine. Our vision is to build a world class Laboratory Informatics Company, that transforms scientific experimentation by bringing the digital laboratory of the future to the research laboratories of today. Type: | 0 | 0 | 0 | 2 |
 | Koniku Bio is TechTM At Koniku Inc., we take the view that a biological neuron is a *material*. An intelligent material or component to be utilized in real life products or devices. Clearly, this proposition opens up a unique set of technology challenges, solvable. It simultaneously offers up an unimaginably vast trove of opportunities. Opportunities ranging from pure-play neurotech, *living devices* to advanced brain-machine interfaces. Koniku is the worlds first corporation of its kind. We are the leading brand in neurotechnology devices. Our goal is to harness the "raw" biological basis of intelligence. Our maxim is: “Bio is TechTM”. We are … Type: | 9 | 3 | 6 | 4 |
 | Vortex Biosciences Circulating Tumor Cells (CTCs) are cancer cells, which have detached from the primary tumor and have entered the patient bloodstream. These CTCs are known to be the key cause of secondary tumors in patients. As a result, the number and type of CTCs in a patient blood is highly indicative of the status of cancer in that patient. CTCs provide insight into the source of the primary tumor, grade, invasiveness, response to therapy and recurrence. As an indication, approximately 1.5 million new cancer patients are diagnosed per year in the United States, and around 20 million existing patients are undergoing … Type: | 1 | 1 | 1 | 5 |
 | Sesame Pay half. Be whole. Sesame is building a radically new healthcare system for uninsured Americans and those with high-deductible plans. The company's marketplace replaces historically inefficient, expensive healthcare with a direct connection – either virtually or in-person – between patients and physicians. This direct connection enables Sesame to offer doctor visits, labs, imaging and prescription drugs at half the price. Founders include a Harvard PhD in health policy and economics; a former Goldman Sachs analyst; and entertainment executive and healthcare reformer David Goldhill, author of the legendary cover story in The Atlantic, "How American Health Care Killed My Father." Sesame … Type: | 7 | 2 | 6 | 140 |
 | Multus Feeding food. 🔵 What do we do? Multus is reinventing growth media for cell culture in cultivated meat and life science. From growth factors to serum-free supplements, we partner with companies looking for media breakthroughs to help accelerate their progress and de-risk their supply chain. 🔵 How do we do it better? We use a groundbreaking combination of data science, high-throughput automation and ISO-certified manufacturing to develop ingredients and formulations that reduce costs, eliminate animal-sourced components and enable scale-up. 🔵 Why do we do it? Our Mission is to make cultivated meat the sustainable and affordable choice, for everyone. To … Type: | 16 | 3 | 11 | 27 |
 | Plastomics, Inc. Plastomics is developing next generation trait delivery technology that leverages the power of chloroplasts. Plastomics' novel trait delivery technology harnesses the power of the plant cell to create crops than can better withstand the pressure of insects, diseases and weeds and that are more efficient and deliver higher yields. Plastomics technology will give seed companies the benefits of simplified product development, more effective products and new market opportunities. plant transformation, chloroplast transformation, agricultural biotechnology, soybean transformation, and corn transformation Type: | 1 | 1 | 0 | 28 |
 | Immunophotonics, Inc. Interventional Immuno-Oncology Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate polymer IP-001 for the treatment of solid tumor cancers. IP-001 has unique physio-chemical and immunological properties that allows it to ignite a systemically active cancer immunotherapy from a routine tumor ablation; a minimal invasive intervention that destroys tumors and in doing so liberates tumor antigens. IP-001 enhances interactions of tumor antigens with the immune system, improves the motility of tumor infiltrating T cells, promotes their … Type: | 1 | 0 | 1 | 17 |
 | Future Fields We use fruit flies to help scientists change the world. Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngineTM, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science. Future Fields is a proud business member of 1% for the Planet, a … Type: | 6 | 0 | 5 | 42 |
 | CeQur Our mission is to simplify the lives of people with diabetes CeQur®, a medical device company dedicated to simplifying mealtime insulin delivery for individuals on multiple daily injections, manufactures CeQur Simplicity, a simple-to-use wearable insulin delivery device enabling discreet, convenient and injection-free bolus dosing. In June 2024, the company announced the FDA's recent 510(k) clearance of CeQur Simplicity for an extended wear duration from 3 to 4 days. One CeQur Simplicity 4-day wearable patch holds up to 200 units of rapid-acting insulin administered in two-unit increments and replaces, on average, twelve daily mealtime injections over four days. CeQur is headquartered … Type: | 1 | 1 | 0 | 116 |
 | AbCellera Antibody discovery engine AbCellera discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. Antibody Discovery, Cell Culture, Antibody Therapies, Protein Analysis, Microfluidic Single Cell Analysis, Single Cell Genomics, Monoclonal Antibody Discovery, Cell Enrichment, Cell Screening, Cell Recovery, Protein engineering, T cell engagers, and Bispecifics Type: | 11 | 1 | 4 | 584 |
 | Assay Genie Creating World-Class Assays, Immunoassays, Antibodies & Proteins Assay Genie is a global life reagents company with over 120,000 products including immunoassays, antibodies, proteins & activity assays for research and development scientists. Founded in 2017, Assay Genie has offices in Dublin, Ireland & London, UK. With distributors in over 70 countries, Assay Genie works with scientists all around the World and counts Pfizer, J&J, Harvard University and many more of the World’s leading companies & universities among its customers. Company Achievements & Core Technologies Since its inception in 2017, Assay Genie has gone form strength-to-strength. The company began by building a … Type: | 0 | 0 | 0 | 16 |
 | Habitual Type 2 diabetes care, reimagined. Weight loss is just the beginning. ⚖️ Clinically proven weight loss programmes with total diet replacement and medication 📱 App-based tracking, expert-written behaviour change content, professional and peer support. 🌈 NHS diabetes remission partnerships 🔬 Active clinical research 👉 www.tryhabitual.com Type: | 2 | 1 | 1 | 24 |
 | Barinthus Biotherapeutics Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates. Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of … Type: | 12 | 4 | 6 | 122 |
 | BioLogos BioLogos explores God’s Word and God’s World to inspire authentic faith for today. BioLogos explores God’s Word and God’s World to inspire authentic faith for today. evolution, creationism, intelligent design, biblical scholarship, genetics, cell biology, christianity, jesus, theology, creation care, bioethics, christian ethics, and human identity Type: | 0 | 0 | 0 | 34 |
 | Auto21 [Automatic translation follows] Cars and mobility of the 21st century Type: | 1 | 0 | 0 | N/A |
![UserWise [ClariMed, Inc.]](/media/logo/152181_nJhItqF.jpeg){kind=logo} | UserWise [ClariMed, Inc.] UserWise is now ClariMed. Uniting global expertise in medical product development and regulatory services. At ClariMed we are clarifying the pathway for usable medical products. We are a human-centered medical device development and regulatory services company accelerating time to market, improving safety, and enabling innovation for pharma and medtech teams while enhancing outcomes and enriching the quality of life for their users. Through embedding human factors and other user focused and risk-mitigated services we partner with our clients to develop innovative medical technologies and make them accessible to the communities who need them. Industries served: Pharma, Biotech, Medtech/device Services offered: … Type: | 0 | 0 | 0 | 64 |
 | CytoReason The First Cell-Centered Computational Model of Human Disease CytoReason is a tech company transforming biopharma’s decision-making from trial and error to data-driven using an AI Platform of computational disease models. With its extensive database of public and proprietary data, the company maps human diseases – tissue by tissue and cell by cell. Researchers of all levels rely on CytoReason’s technology to make data-driven decisions across the drug development life cycle. Scientists can identify potential targets, prioritize indications, and stratify patient populations. Program leaders can compare drugs across multiple diseases or multiple drugs within a single disease. C-level executives can gain … Type: | 7 | 1 | 4 | 132 |
 | UGECAM PACA et Corse [Automatic translation follows] • UGECAM Group: - 1st private non-profit healthcare operator - involved in the areas of follow-up and rehabilitation care - 225 establishments, 14,500 beds and places, and 13,500 professionals. - 13 regional departments, each managing around twenty health and/or medico-social establishments in France • UGECAM PACA Corse: - presence in 6 departments - quality care offer, as close as possible to the needs of the population - 6 specialized health establishments for Continuing Care and Rehabilitation (SSR) - 20 medico-social structures for children and adults with motor and/or mental disabilities - recognized health player - preservation and … Type: | 9 | 2 | 7 | 459 |
 | Actipulse Neuroscience® Neuromodulation therapeutics from the hospital, directly to the home of the patient. A Paris Brain Institute company. Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Neuromodulation, Depression, Alzheimer's, and Neurotech Type: | 5 | 4 | 0 | 37 |
 | Prevent Cancer Foundation Creating a world where cancer is preventable, detectable and beatable for all. The Prevent Cancer Foundation® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable. The Foundation is rising to meet the challenge of reducing cancer deaths by 40% by 2035. To achieve this, we are committed to investing $20 million for innovative technologies … Type: | 6 | 2 | 4 | 37 |
 | CHPA CHPA is the 143-year-old national trade association representing the leading manufacturers and marketers of OTC meds. Founded in 1881, the Consumer Healthcare Products Association (CHPA) is the national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $7.33, contributing a total of $167 billion in savings each year. CHPA is committed to promoting the increasingly vital role of OTC medicines and dietary supplements in America’s healthcare system through science, education, and advocacy. Visit www.chpa.org to learn more. Over-the-counter … Type: | 9 | 1 | 9 | 115 |
 | MiTeGen Crystallography and Cryo-EM Tools, News, Developments, and Innovations MiTeGen designs and manufactures products for X-ray diffraction and crystallography of proteins and small molecule/inorganic compounds, and for manipulation and measurement of small samples in cell biology, histology, clinical diagnostics, entomology, archeology, and geology. Our customers include academic, government, medical, pharamaceutical and industrial laboratories in more than 40 countries. MiTeGen can deliver custom products to meet your specifications. Research and Development, Crystallography, X-ray Diffraction, Crystallization, Engineering, and CryoEM Type: | 7 | 0 | 6 | 11 |
 | NuCalm Reduce Stress and Improve Sleep. All Natural, Easy-to-Use, and Clinically Proven Neuroscience Technology. Dr. Blake Holloway, the mind behind NuCalm, spent years exploring research about how our bodies and brains work. More than 30 years ago, Dr. Holloway began a quest to help people suffering from acute PTSD without using narcotics. This mission led to years of research, development, and clinical testing and, ultimately, a breakthrough technology platform that safely and predictably allows you to manage your mental states on demand. We do this through patented, clinically-proven neuroacoustic software that guides your brain waves to different frequencies, from the highest … Type: | 3 | 1 | 2 | 8 |
 | Nexxt Spine Grow with Us. Nexxt Spine is a medical device company dedicated to increasing procedural efficiency and patient outcomes through development of innovative products, manufactured on the most technologically advanced platforms, and utilizing irreproachable quality standards to treat painful and debilitating spinal pathologies. Since its inception in 2009, Nexxt Spine has worked with key opinion leaders to develop innovative products with an emphasis on streamlining procedural efficiency and improving patient outcomes. With 16 product lines currently available for sale within the U.S., the company manufacturers 100% of all spinal implants and 95% of surgical instruments on-site within their state of the … Type: | 0 | 0 | 0 | 53 |
 | BTE The technology of human performance - http://www.btetechnologies.com BTE’s expertise is human physical performance evaluation and treatment. Our Rehabilitation Equipment provides advanced evidence-based physical therapy systems for clinics, hospitals, and private practices. With BTE, people and companies achieve better outcomes. Physical Therapy, Occupational Therapy, Athletic Training, Chiropractic, Medical Devices, Rehabilitation, Rehabilitation Equipment, and physiotherapy Type: | 1 | 0 | 0 | 213 |
 | Amicus Therapeutics Our passion for making a difference unites us. We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Amicus is the Latin word for friend. This name signifies our collaborative approach to developing medicines by incorporating the patient perspective every step of the way. Our company was founded by an entrepreneur who embarked on a life-long journey to transform the lives of those living with devastating conditions when two of his children were diagnosed with a rare disease. That spirit of empathy, compassion, and tenacity permeates our culture … Type: | 0 | 0 | 0 | 594 |
 | PrimaCare Medical Centers For more than 30 years, PrimaCare has been meeting the medical needs of the Dallas/Fort Worth Metroplex, and our mission has always been the same: to provide quality healthcare to the patients in the communities we serve with courtesy, convenience and compassion. Accredited by The Joint Commission and COLA for providing a superior healthcare experience, we're committed to delivering a wide range of services with compassionate care. With 11 locations conveniently placed throughout the Metroplex, we're always right around the corner. Open seven days a week. We pride ourselves in providing Convenient Family Care. Visit us in: Cedar Hill Frisco … Type: | 1 | 0 | 1 | 79 |
 | SCYNEXIS, Inc. Committed to protecting the world against dangerous and difficult-to-treat fungal pathogens At SCYNEXIS, we are bringing a ground-breaking class of drugs to the battle by developing innovative products that have the strength, safety, and versatility to defeat even the most insidious fungal diseases. We are committed to positively impacting the lives of patients suffering from fungal infections — from the most common to the difficult-to-treat and deadliest. (NASDAQ: SCYX) The SCYNEXIS team has deep expertise in anti-infective drug development and marketing, which can be leveraged to advance ibrexafungerp from clinical development to commercialization. Antifungals, Drug Development, Biotech, Infectious Disease, and … Type: | 3 | 0 | 1 | 63 |
 | Action Medical Research We fight for children's lives We fight for answers. Answers that can lead to cures, treatment and medical breakthroughs. Action Medical Research is a UK-wide charity funding vital research to help sick and disabled babies and children. We fight for answers that can lead to cures, treatments and medical breakthroughs for some of the toughest fights our children face. Since we began in 1952, we have been funding medical breakthroughs and almost everyone has been touched in some way by our groundbreaking work - like the first polio vaccines in the UK, ultrasound in pregnancy and the rubella vaccine. Today, … Type: | 5 | 1 | 2 | 78 |
 | D.tec International Ltd. DrugWipe is the global leader for police roadside driver drug screening and is also used extensively in the workplace. D.tec International founded in 1996 are experts in the provision of Drug and Alcohol screening services for both blue chip companies and the public sector. Drug and Alcohol Screening Solutions, Drug and Alcohol Policy Construction, Drug and Alcohol Awareness Training, Health and Safety, Drug Screening, and Alcohol Screening Type: | 0 | 0 | 0 | 8 |
 | COHESIVES LA REVOLUTION DEEPTECH DU WOUND CARE & SUTURING COHESIVES is a co-development platform for medical devices using our adhesive technology. We are based in DIJON, France. Adhesive, suture, and wound dressing Type: | 6 | 4 | 3 | 12 |
 | AbilyCare The digital solution to measure one's walk and balance Based on French research, Abilycare was developed by and for practitioners. AbilyCare is a solution that measures walk and balance in order to prevent frailty risks at any moment of our life. It's a medical device (certification in progress), easy and fast to use in order to : - detect early signs of frailty - develop preventive actions to initiate the process of reversibility - monitor the patient's state over time and measure the benefit of a rehabilitation or prevention program Type: | 14 | 6 | 10 | 6 |
 | Igyxos Igyxos develop more effective/efficient infertility treatment for patients Igyxos is a biotechnology company based out of CENTRE INRAe VAL DE LOIRE SITE DE TOURS, NOUZILLY, France. Biotechnologie, Fertilité, and anticorps monoclonal Type: | 2 | 1 | 2 | 11 |
 | GCS ACHATS NOUVELLE AQUITAINE [Automatic translation follows] Coordination of regional purchases for health, social and medical-social institutions. 🏆♻ 2023_ Winner of the Purchasing Strategy Award and implementation of CSR in purchasing. [Cristal des Achats] Coordination of regional purchases for health, social and medical-social institutions Purchases, Medical devices, Medicines, Premises maintenance, Food, Helicopter medical transport, Textiles, DASRI, and Periodic technical inspections Type: | 4 | 4 | 1 | 1 |
 | Nîmes Sport Santé [Automatic translation follows] Health through Movement Nîmes Sport Santé is an association promoting health through the practice of adapted physical and sports activity. Since its creation in 2002, the association has become a recognized and essential player in sports-health in Nîmes and its region thanks to its actions aimed at people with chronic illnesses, disabilities, or aging... MISSIONS: - Improve health and contribute to the physical, mental, and social well-being of people by having them practice adapted physical activities. - Promote "Sport-Health" as an evaluated, organized, individualized and secure approach, using sport as a tool for health. - Organize, develop … Type: | 0 | 0 | 0 | 6 |
 | Urgo Medical Make a difference by helping healthcare professionals heal patients Urgo Medical is the wound-healing division of URGO group. Every day our 1600 employees are passionate about creating, developing and promoting highly innovative dressings and global solutions to heal people suffering from wounds. Our mission, as The Healing Company, is to make a significant difference for patients, healthcare professionals and the healthcare systems. In order to fulfil our mission: • Patient is at the heart of everything we do. • We keep innovating to develop the best in class solutions. • We have a pioneer and entrepreneurial mindset and we dare … Type: | 2 | 1 | 1 | 614 |
 | Ed'Innov Santé Custom-made accompaniment Ed' Innov Saté is a custom training organization, a public health project consulting firm and a creative agency. Ed' Innov Santé supports teams in the optimization of their Care Paths but also in the creation or optimization of Therapeutic Patient Education programs. As a leader in these themes, Ed' Innov santé has, to date, supported more than 250 health establishments with an innovative and highly differentiating approach in Metropolitan France, French overseas departments and territories and French Polynesia (projects in Africa to come). Ed' Innov Santé is an independent organization, regardless of the source of funding, with an … Type: | 4 | 0 | 4 | 3 |
 | Clinique de l'Escrebieux [Automatic translation follows] We take care of you. The Clinique de l'Escrebieux is a private 95-bed facility that opened its doors in December 1997. Located 5 km from Douai, it is in the heart of the Artois Territory and mainly welcomes patients from the Nord Pas-de-Calais region. It is focused on treating anxiety and depressive disorders in adults, men and women, and on treating psychiatric disorders in people over 65 years old. For this purpose, a new unit that welcomed its first patients in the summer of 2015 and dedicated to geriatric psychiatry was entirely created. In September 2009, it … Type: | 2 | 1 | 1 | 17 |
 | OMéDIT Centre-Val de Loire [Automatic translation follows] Observatory of Medicines💊, Medical Devices💉, Therapeutic Innovations🧬 🔎 OMéDIT Centre-Val de Loire is a regional structure for support, evaluation and independent scientific expertise, placed with the ARS. It is strongly committed to supporting and implementing quality, safety and medico-economic efficiency approaches related to medicines and medical devices, for patients and healthcare professionals. In charge of coordinating a coordinated policy on the proper use of health products and good practices, OMéDIT participates in the fight against avoidable iatrogenic diseases: ➡️ by disseminating all information on the proper use of health products to all health professionals involved in the … Type: | 11 | 2 | 7 | 8 |
 | OMEDIT Nouvelle-Aquitaine Guadeloupe Guyane [Automatic translation follows] Observatory of Medicine, Medical Devices and Therapeutic Innovation OMEDIT Nouvelle-Aquitaine Guadeloupe and Guyana is a support and expertise structure participating in the Regional Vigilance and Support Network (RREVA), for the proper use of medicines and medical devices. This regional structure with medico-economic skills provides support for the development of contracts for improving the quality and efficiency of care (CAQES) Type: | 6 | 2 | 6 | 19 |
 | Centre hospitalier Métropole Savoie - CHMS [Automatic translation follows] The CHMS is located in Chambéry and Aix-les-Bains. It is the support facility for the GHT Savoie/Belley. A reference facility for the Savoie Belley area, the Métropole Savoie hospital center is located on two sites in Chambéry and Aix-les-Bains. Each year, the two adult emergency departments, the pediatric emergency department and the gynecological emergency department receive more than 94,000 patients 24 hours a day. The Emergency department includes the only adult intensive care unit in the area. Its recent technical platform allows almost all diagnostic and therapeutic procedures to be performed. All types of surgery are performed, … Type: | 5 | 4 | 1 | 728 |
 | Centre de Santé Mentale Angevin (CESAME) [Automatic translation follows] Public mental health institution - Maine-et-Loire, Pays de la Loire A public mental health institution, CESAME provides psychiatric care to children, adolescents and adults. The institution is organized into sectors covering the department of Maine-et-Loire, with the exception of the population of the districts of Cholet and Saumur. Each psychiatric sector has, apart from full hospitalization, several places of care distributed throughout its territory: Medico-Psychological Center (CMP), Part-Time Therapeutic Reception Center (CATTP), day centers or hospitals, therapeutic apartments, permanent locations... At the heart of this system, the CMP occupies a special place. Psychiatry, Outpatient, Care, Medicine, Medico-Psychological … Type: | 6 | 1 | 6 | 273 |
Startup